High Tumor Mutational Burden May Predict Improved Response to Immunotherapy in Head and Neck Cancer Patients

被引：0
|
作者：
Stewart, M. [1 ]
Reddy, C. A. [2 ]
Woody, N. M. [2 ]
Sussman, T. [3 ]
Yilmaz, E. [1 ]
Geiger, J. L. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol, Cleveland, OH 44106 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
162
引用
收藏
页码：E43 / E43
页数：1
相关论文
共 50 条
  • [1] High Tumor Mutation Burden in Small-Cell Lung Cancer May Predict Improved Immunotherapy Response
    不详
    ONCOLOGY-NEW YORK, 2017, 31 (11): : 836 - +
  • [2] MHC-I genotype and tumor mutational burden predict response to immunotherapy
    Goodman, Aaron M.
    Castro, Andrea
    Pyke, Rachel Marty
    Okamura, Ryosuke
    Kato, Shumei
    Riviere, Paul
    Frampton, Garrett
    Sokol, Ethan
    Zhang, Xinlian
    Ball, Edward D.
    Carter, Hannah
    Kurzrock, Razelle
    GENOME MEDICINE, 2020, 12 (01)
  • [3] MHC-I genotype and tumor mutational burden predict response to immunotherapy
    Aaron M. Goodman
    Andrea Castro
    Rachel Marty Pyke
    Ryosuke Okamura
    Shumei Kato
    Paul Riviere
    Garrett Frampton
    Ethan Sokol
    Xinlian Zhang
    Edward D. Ball
    Hannah Carter
    Razelle Kurzrock
    Genome Medicine, 12
  • [4] Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Psyrri, Amanda
    CANCERS, 2020, 12 (11) : 1 - 23
  • [5] Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy
    Crow, Jennifer
    Samuel, Glenson
    Godwin, Andrew K.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2019, 19 (12) : 1079 - 1088
  • [6] The predictive power of tumor mutational burden in lung cancer immunotherapy response is influenced by patients' sex
    Wang, Shixiang
    Zhang, Jing
    He, Zaoke
    Wu, Kai
    Liu, Xue-Song
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (10) : 2840 - 2849
  • [7] Persistent Tumor Mutational Burden (pTMB) May Predict Response to Immune Checkpoint Inhibitors
    Smith, Katherine E. R.
    Markovic, Svetomir N.
    CLINICAL CHEMISTRY, 2024, 70 (01) : 25 - 26
  • [8] Tumor mutational burden as predictive factor of response to immunotherapy
    Gonzalez-Cao, Maria
    Viteri, Santiago
    Karachaliou, Niki
    Aguilar, Andres
    Jose Garcia-Mosquera, Juan
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S358 - S361
  • [9] Sarcopenia may predict recurrence in patients with head and neck cancer
    Colback, Angela A.
    Arkfeld, Daniel V.
    Paydar, Alireza
    Raslan, Osama
    Cates, Daniel J.
    Abouyared, Marianne
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2025, 47 (01): : 282 - 288
  • [10] Association of driver genes with high-tumor mutation burden and outcome in patients with head and neck cancer: Implications for immunotherapy.
    Chen, Yu
    Chen, Chuan-ben
    Zheng, Xiao-bin
    Gao, Xuan
    Jun, Liu
    Xiong, Jia-ni
    Lin, Jin
    Xu, Yaping
    Guan, Yan-Fang
    Li, Yi
    Huang, Yingying
    Xia, Xuefeng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345